{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:26:37Z","timestamp":1757611597409,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.canrad.2025.104683","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T12:12:49Z","timestamp":1754914369000},"page":"104683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surgery for all patients with T1N0 non-small cell lung cancer?"],"prefix":"10.1016","volume":"29","author":[{"given":"Claudia","family":"Pouypoudat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Thureau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaniss","family":"Belaroussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9tienne","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.canrad.2025.104683_bib0180","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"10.1016\/j.canrad.2025.104683_bib0185","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canrad.2021.11.005","article-title":"Radiotherapy for primary lung cancer","volume":"26","author":"Khalifa","year":"2022","journal-title":"Cancer Radiother"},{"issue":"4","key":"10.1016\/j.canrad.2025.104683_bib0190","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.chest.2024.05.026","article-title":"The proposed ninth edition TNM classification of lung cancer","volume":"166","author":"Detterbeck","year":"2024","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.canrad.2025.104683_bib0195","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.21037\/tcr.2019.10.46","article-title":"Selective lymph node dissection for clinical T1 stage non-small cell lung cancer","volume":"8","author":"Zhao","year":"2019","journal-title":"Transl Cancer Res"},{"year":"2025","journal-title":"J Natl Compr Canc Netw","article-title":"Surgery and survival in early-stage lung cancer: learning from real-world data JNCCN 360 [Internet]","key":"10.1016\/j.canrad.2025.104683_bib0200"},{"issue":"10335","key":"10.1016\/j.canrad.2025.104683_bib0205","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.canrad.2025.104683_bib0210","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S2213-2600(24)00010-9","article-title":"Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial","volume":"12","author":"Steinfort","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"21","key":"10.1016\/j.canrad.2025.104683_bib0215","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group","volume":"26","author":"Pignon","year":"2008","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2025.104683_bib0220","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.22.02186","article-title":"Adjuvant osimertinib for resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer: updated results from the phase III randomized ADAURA trial","volume":"41","author":"Herbst","year":"2023","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.canrad.2025.104683_bib0225","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"issue":"6\u20137","key":"10.1016\/j.canrad.2025.104683_bib0230","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.canrad.2023.07.012","article-title":"[Stereotactic radiotherapy for operable stage I non-small cell lung cancer]","volume":"27","author":"Martin","year":"2023","journal-title":"Cancer Radiother"},{"issue":"5","key":"10.1016\/j.canrad.2025.104683_bib0235","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ijrobp.2015.07.2278","article-title":"prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG0403","volume":"93","author":"Nagata","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.canrad.2025.104683_bib0240","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jamaoncol.2018.1251","article-title":"Stereotactic body radiation therapy for operable early-stage lung cancer: findings from the NRG Oncology RTOG 0618 trial","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2025.104683_bib0245","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104683_bib0250","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.radonc.2015.08.011","article-title":"Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: results from the ROSEL multicenter randomized trial","volume":"117","author":"Louie","year":"2015","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.canrad.2025.104683_bib0255","first-page":"e427","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104683_bib0260","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1053\/j.semtcvs.2021.06.024","article-title":"Decreasing prevalence of benign etiology in resected lung nodules suspicious for lung cancer over the last decade","volume":"34","author":"Ma","year":"2022","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.canrad.2025.104683_bib0265","doi-asserted-by":"crossref","first-page":"109976","DOI":"10.1016\/j.radonc.2023.109976","article-title":"What is the predictive value of RECIST criteria following stereotactic lung radiation?","volume":"190","author":"Gulstene","year":"2024","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104683_bib0270","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.athoracsur.2018.10.015","article-title":"Comparison between stereotactic radiotherapy and sublobar resection for non-small cell lung cancer","volume":"107","author":"Tamura","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.canrad.2025.104683_bib0275","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s12094-020-02459-8","article-title":"Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodules","volume":"23","author":"Tomita","year":"2021","journal-title":"Clin Transl Oncol"},{"issue":"17","key":"10.1016\/j.canrad.2025.104683_bib0280","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1016\/j.ejca.2014.09.006","article-title":"Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: a propensity score matching analysis","volume":"50","author":"Matsuo","year":"2014","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.canrad.2025.104683_bib0285","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.4143\/crt.2022.1581","article-title":"Sublobar resection versus stereotactic body radiation therapy for clinical stage I non-small cell lung cancer: a study using data from the Korean Nationwide Lung Cancer Registry","volume":"55","author":"Yun","year":"2023","journal-title":"Cancer Res Treat"},{"unstructured":"Timmerman R. JoLT-Ca sublobar resection (SR) versus stereotactic ablative radiotherapy (SAbR) for lung cancer (STABLE-MATES). ClinicalTrials.gov ID NCT02468024.","key":"10.1016\/j.canrad.2025.104683_bib0290"},{"issue":"2","key":"10.1016\/j.canrad.2025.104683_bib0295","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2011.06.029","article-title":"Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery","volume":"101","author":"Palma","year":"2011","journal-title":"Radiother Oncol"},{"unstructured":"Moghanaki D, Harpole DH. CSP #2005\u00a0\u2013\u00a0Veterans Affairs Lung Cancer Surgery or Stereotactic Radiotherapy Trial (VALOR). Completion date 30.09.2026. https:\/\/www.vacsp.research.va.gov\/CSP_2005\/CSP_2005.asp.","key":"10.1016\/j.canrad.2025.104683_bib0300"},{"issue":"1","key":"10.1016\/j.canrad.2025.104683_bib0305","doi-asserted-by":"crossref","first-page":"147","DOI":"10.21037\/jtd-23-1201","article-title":"Change in quality of life of stage IA non-small cell lung cancer after surgery or radiation therapy","volume":"16","author":"Zhang","year":"2024","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.canrad.2025.104683_bib0310","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.radonc.2018.04.013","article-title":"Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer","volume":"128","author":"Paix","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104683_bib0315","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2020.01.011","article-title":"Cost-effectiveness of stereotactic body radiation therapy versus video assisted thoracic surgery in medically operable stage I non-small cell lung cancer: a modeling study","volume":"141","author":"Wolff","year":"2020","journal-title":"Lung Cancer"},{"issue":"18","key":"10.1016\/j.canrad.2025.104683_bib0320","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected EGFR-mutated non-small-cell lung cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N Engl J Med"},{"issue":"10308","key":"10.1016\/j.canrad.2025.104683_bib0325","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.canrad.2025.104683_bib0330","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(22)00518-6","article-title":"Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS\/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial","volume":"23","author":"O\u2019Brien","year":"2022","journal-title":"Lancet Oncol"},{"issue":"10405","key":"10.1016\/j.canrad.2025.104683_bib0335","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(23)01384-3","article-title":"Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial","volume":"402","author":"Chang","year":"2023","journal-title":"Lancet"},{"issue":"16\u00a0suppl.","key":"10.1016\/j.canrad.2025.104683_bib0340","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1200\/JCO.2025.43.16_suppl.8003","article-title":"SWOG\/NRG S1914: randomized phase III trial of induction\/consolidation atezolizumab+SBRT versus SBRT alone in high risk, early-stage NSCLC","volume":"43","author":"Simone","year":"2025","journal-title":"J Clin Oncol"},{"issue":"Suppl.","key":"10.1016\/j.canrad.2025.104683_bib0345","doi-asserted-by":"crossref","first-page":"100746","DOI":"10.1016\/j.iotech.2024.100746","article-title":"1170 Stereotactic body radiotherapy (SBRT) with pembrolizumab (pembro) for unresected stage I\/II non-small cell lung cancer (NSCLC): the randomized, double-blind, phase III KEYNOTE-867 study","volume":"24","author":"Pircher","year":"2024","journal-title":"Immunooncol Technol"},{"issue":"16_suppl","key":"10.1016\/j.canrad.2025.104683_bib0350","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS8607","article-title":"Phase 3 study of durvalumab with SBRT for unresected stage I\/II, lymph-node negative NSCLC (PACIFIC-4\/RTOG3515)","volume":"41","author":"Robinson","year":"2023","journal-title":"J Clin Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832182500099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832182500099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:41:43Z","timestamp":1756932103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832182500099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":35,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S127832182500099X"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104683","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgery for all patients with T1N0 non-small cell lung cancer?","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104683"}}